Literature DB >> 14525680

Soy, garlic, and ginkgo biloba: their potential role in cardiovascular disease prevention and treatment.

Christopher D Gardner1, Mark Messina, Larry D Lawson, John W Farquhar.   

Abstract

There are hundreds of foods, nutrients, herbs, and botanicals that have "bioactive" constituents with potential human health benefits. Three of these are discussed in this review: soy, garlic, and ginkgo biloba. Each of these three choices involves an ingestible item composed of a complex mixture of bioactive agents. For each of these three, there is a large and growing body of research suggesting potential cardiovascular health benefits. And for each there is at least some level of disagreement or controversy. The focus of this review is on results from recent human clinical trials.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14525680     DOI: 10.1007/s11883-003-0037-7

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  45 in total

1.  Hypocholesterolemic effect of an enteric-coated garlic supplement.

Authors:  D Kannar; N Wattanapenpaiboon; G S Savige; M L Wahlqvist
Journal:  J Am Coll Nutr       Date:  2001-06       Impact factor: 3.169

2.  Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials.

Authors:  M H Pittler; E Ernst
Journal:  Am J Med       Date:  2000-03       Impact factor: 4.965

3.  The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women.

Authors:  C D Gardner; K A Newell; R Cherin; W L Haskell
Journal:  Am J Clin Nutr       Date:  2001-04       Impact factor: 7.045

4.  Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion.

Authors:  J Rowin; S L Lewis
Journal:  Neurology       Date:  1996-06       Impact factor: 9.910

5.  A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids.

Authors:  M Steiner; A H Khan; D Holbert; R I Lin
Journal:  Am J Clin Nutr       Date:  1996-12       Impact factor: 7.045

6.  A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins.

Authors:  J R Crouse; T Morgan; J G Terry; J Ellis; M Vitolins; G L Burke
Journal:  Arch Intern Med       Date:  1999-09-27

7.  Genistein, daidzein and glycitein inhibit growth and DNA synthesis of aortic smooth muscle cells from stroke-prone spontaneously hypertensive rats.

Authors:  W Pan; K Ikeda; M Takebe; Y Yamori
Journal:  J Nutr       Date:  2001-04       Impact factor: 4.798

8.  Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial.

Authors:  J L Isaacsohn; M Moser; E A Stein; K Dudley; J A Davey; E Liskov; H R Black
Journal:  Arch Intern Med       Date:  1998-06-08

9.  Effect of garlic on total serum cholesterol. A meta-analysis.

Authors:  S Warshafsky; R S Kamer; S L Sivak
Journal:  Ann Intern Med       Date:  1993-10-01       Impact factor: 25.391

10.  Garlic as a lipid lowering agent--a meta-analysis.

Authors:  C Silagy; A Neil
Journal:  J R Coll Physicians Lond       Date:  1994 Jan-Feb
View more
  2 in total

1.  Does Ginkgo biloba reduce the risk of cardiovascular events?

Authors:  Lewis H Kuller; Diane G Ives; Annette L Fitzpatrick; Michelle C Carlson; Carla Mercado; Oscar L Lopez; Gregory L Burke; Curt D Furberg; Steven T DeKosky
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-11-24

2.  The relaxant effect induced by Allium sativum L. bulb aqueous extract on rat isolated trachea.

Authors:  Badreddine Fehri; Mueen K K Ahmed; Jean-Marc Aiache
Journal:  Pharmacogn Mag       Date:  2011-01       Impact factor: 1.085

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.